We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence and Brief Communications |

Inadequate Proof of Adverse Outcome Due to the Use of Fluconazole in Critically Ill Patients

Stijn I. Blot, RN, MA; Eric A Hoste, MD; Koenraad H. Vandewoude, MD; Francis A. Colardyn, MD
Arch Surg. 2000;135(9):1114. doi:.
Text Size: A A A
Published online


Rocco et al1 found that patients treated with fluconazole had a longer length of stay in the intensive care unit and hospital and a higher mortality. This study has several shortcomings, limiting the conclusions being made. The patient groups are not comparable. The authors should have used the Acute Physiology and Chronic Health Evaluation III expected mortality instead of the score when they compared groups for outcome, as underlying disease can make an important difference on mortality. Furthermore, the fluconazole-treated patients are more debilitated and sick, suggested by the higher use of steroids and antibiotics and the higher number of yeast infection sites. In general, fungal infections occur in patients with a strongly debilitated physical condition who are already hospitalized for a longer period.2 Fungal infections might have an attributable mortality.3 Hence, we are convinced that the excess length of stay as well as the worse prognosis of these patients is more a result of this population being less healthy rather than a result of the use of fluconazole.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature

Users' Guides to the Medical Literature
Regression Modeling With Dichotomous Target Variables